Immunogenicity of ChAdOx1 nCoV-19 Booster Vaccination Following Two CoronaVac Shots in Healthcare Workers

During the early phase of the COVID-19 pandemic, several countries, including Thailand, provided two shots of CoronaVac to healthcare workers. Whereas ChAdOx1 nCoV-19 is the promising vaccine as the booster dose, the data on immunogenicity when administered after CoronaVac have been limited. The pur...

Full description

Bibliographic Details
Main Authors: Wisit Prasithsirikul, Krit Pongpirul, Tanawin Nopsopon, Phanupong Phutrakool, Wannarat Pongpirul, Chatpol Samuthpongtorn, Pawita Suwanwattana, Anan Jongkaewwattana
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/2/217